These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3542579)

  • 1. Role of platelet and vascular eicosanoids in the pathophysiology of ischemic heart disease.
    Chierchia S; Patrono C
    Fed Proc; 1987 Jan; 46(1):81-8. PubMed ID: 3542579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
    N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2 biosynthesis in human disease.
    FitzGerald GA; Healy C; Daugherty J
    Fed Proc; 1987 Jan; 46(1):154-8. PubMed ID: 3100340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of physiological and pathophysiological effects of thromboxane A2.
    Ogletree ML
    Fed Proc; 1987 Jan; 46(1):133-8. PubMed ID: 2948837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
    Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
    Fitzgerald DJ; Wright F; FitzGerald GA
    Circ Res; 1989 Jul; 65(1):83-94. PubMed ID: 2500270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stenocardia: coronary atherosclerosis, coronary spasm, microcirculatory disorders].
    Nikitin GA; Kuznetsov AB; Godin VA
    Vestn Akad Med Nauk SSSR; 1985; (9):82-7. PubMed ID: 3904266
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prostaglandins and thromboxane A2 on coronary vessel tone--mechanisms of action and therapeutic implications.
    Schrör K
    Eur Heart J; 1993 Nov; 14 Suppl I():34-41. PubMed ID: 7507439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis.
    Kaneko N; Masuyama J; Nara H; Hirata D; Iwamoto M; Okazaki H; Minota S; Yoshio T
    J Rheumatol; 2002 Oct; 29(10):2106-13. PubMed ID: 12375319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
    Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane biosynthesis in cardiovascular diseases.
    Patrono C; Ciabattoni G; Davi G
    Stroke; 1990 Dec; 21(12 Suppl):IV130-3. PubMed ID: 2260137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and heart disease.
    Beamish RE; Das PK; Karmazyn M; Dhalla NS
    Can J Cardiol; 1985 Jan; 1(1):66-74. PubMed ID: 3850765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.